公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
2020 | Epidemiology and management of HCV Infection | HUNG-CHIH YANG | East Asian Archives of Psychiatry | 0 | 0 | |
2007 | Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape | Bailey J.R; Zhang H; Wegweiser B.W; HUNG-CHIH YANG ; Herrera L; Ahonkhai A; Williams T.M; Siliciano R.F; Blankson J.N. | Journal of Infectious Diseases | 48 | 51 | |
2007 | Experimental approaches to the study of HIV-1 latency | Han Y; Wind-Rotolo M; HUNG-CHIH YANG ; Siliciano J.D; Siliciano R.F. | Nature Reviews Microbiology | 174 | 156 | |
2017 | Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 42 | 39 | |
2018 | Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 18 | 18 | |
2018 | Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study | CHEN-HUA LIU ; Huang Y.-J; Yang S.-S; Chang C.-H; Yang S.-S; HSIN-YUN SUN ; CHUN-JEN LIU ; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 25 | 23 | |
2018 | Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection | CHEN-HUA LIU ; HSIN-YUN SUN ; CHUN-JEN LIU ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Lo Y.-C; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 24 | 21 | |
2019 | A global scientific strategy to cure hepatitis B | Revill P.A; Chisari F.V; Block J.M; Dandri M; Gehring A.J; Guo H; Hu J; Kramvis A; Lampertico P; Janssen H.L.A; Levrero M; Li W; Liang T.J; Lim S.-G; Lu F; Penicaud M.C; Tavis J.E; Thimme R; Arbuthnot P; Boonstra A; Chang K.-M; PEI-JER CHEN ; Glebe D; Guidotti L.G; Fellay J; Ferrari C; Jansen L; Lau D.T.Y; Lok A.S; Maini M.K; Mason W; Matthews G; Paraskevis D; Petersen J; Rehermann B; Shin E.-C; Thompson A; van Bömmell F; Wang F.-S; Watashi K; HUNG-CHIH YANG ; Yuan Z; Yuen M.-F; Block T; Miller V; Protzer U; Bréchot C; Locarnini S; Peters M.G; Schinazi R.F; Zoulim F; Members of the ICE-HBV Working Groups, ICE-HBV Stakeholders Group Chairs, ICE-HBV Senior Advisors | The Lancet Gastroenterology and Hepatology | 338 | 282 | |
2024 | HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative | TAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; Chiang, Chieh; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; JIA-HORNG KAO | JHEP reports : innovation in hepatology | | | |
2022 | Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase | TAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; Hsu, Chen-Yang; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; HSIU-HSI CHEN ; JIA-HORNG KAO | The American journal of gastroenterology | 12 | 12 | |
2024 | Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis | Wu, Hsin-Yun; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; JIA-HUEI TSAI ; Wei, Ming-Han; CHIEH-CHANG CHEN ; CHIEN-CHIH TUNG ; JIA-HORNG KAO ; PEI-JER CHEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
2020 | Hepatitis B reactivation: diagnosis and management | SHANG-CHIN HUANG ; HUNG-CHIH YANG ; JIA-HORNG KAO | Expert Review of Gastroenterology and Hepatology | 18 | 15 | |
2014 | Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 13 | 9 | |
2016 | Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection | Yang W.-T.; Wu L.-W; TAI-CHUNG TSENG ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Medicine (United States) | 19 | 15 | |
2010 | Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model | Lin Y.-J.; Huang L.-R; HUNG-CHIH YANG ; Tzeng H.-T; PING-NING HSU ; Wu H.-L; PEI-JER CHEN ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 61 | 59 | |
2017 | Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Open Forum Infectious Diseases | 42 | 39 | |
2016 | Hepatitis B virus: New therapeutic perspectives | Lin C.-L.; HUNG-CHIH YANG ; JIA-HORNG KAO | Liver International | 45 | 36 | |
2014 | Hepatitis B virus: Pathogenesis and host immune response | HUNG-CHIH YANG ; Shiou-Hwei Yeh ; PEI-JER CHEN ; DING-SHINN CHEN | Viruses and Human Cancer | 0 | 0 | |
2016 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Hepatology | 35 | 31 | |